Ryan N. Henderson

Array ( [id] => 6140841 [patent_doc_number] => 20020001574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'PROCESS OF DELIVERING A POLYNUCLEOTIDE TO A MUSCLE CELL VIA THE VASCULAR SYSTEM' [patent_app_type] => new [patent_app_number] => 09/000533 [patent_app_country] => US [patent_app_date] => 1997-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17089 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20020001574.pdf [firstpage_image] =>[orig_patent_app_number] => 09000533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1313329 [patent_doc_number] => 06613958 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-02 [patent_title] => 'Transgenic mouse model for degeneration of type II collagen in joints' [patent_app_type] => B1 [patent_app_number] => 08/994689 [patent_app_country] => US [patent_app_date] => 1997-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 15584 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613958.pdf [firstpage_image] =>[orig_patent_app_number] => 08994689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887910 [patent_doc_number] => 20020012653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'BILE DUCT PROGENITOR CELLS AND METHODS OF USE' [patent_app_type] => new [patent_app_number] => 08/994539 [patent_app_country] => US [patent_app_date] => 1997-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13972 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20020012653.pdf [firstpage_image] =>[orig_patent_app_number] => 08994539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4074522 [patent_doc_number] => 06069297 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Glucose-6-phosphate dehydrogenase deficient mice and methods of using same' [patent_app_type] => 1 [patent_app_number] => 8/985758 [patent_app_country] => US [patent_app_date] => 1997-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1965 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/069/06069297.pdf [firstpage_image] =>[orig_patent_app_number] => 985758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6426989 [patent_doc_number] => 20020184655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'METHODS FOR THE DEGRADATION AND DETOXIFICATION OF ORGANIC MATERIAL USING URINE PRODUCED BY TRANSGENIC ANIMALS AND RELATED TRANSGENIC ANIMALS AND PROTEINS' [patent_app_type] => new [patent_app_number] => 08/982284 [patent_app_country] => US [patent_app_date] => 1997-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12327 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20020184655.pdf [firstpage_image] =>[orig_patent_app_number] => 08982284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409588 [patent_doc_number] => 06265387 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Process of delivering naked DNA into a hepatocyte via bile duct' [patent_app_type] => 1 [patent_app_number] => 8/975573 [patent_app_country] => US [patent_app_date] => 1997-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10294 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265387.pdf [firstpage_image] =>[orig_patent_app_number] => 975573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 788164 [patent_doc_number] => 06987096 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-17 [patent_title] => 'Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof' [patent_app_type] => utility [patent_app_number] => 08/969689 [patent_app_country] => US [patent_app_date] => 1997-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 26 [patent_no_of_words] => 17552 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/987/06987096.pdf [firstpage_image] =>[orig_patent_app_number] => 08969689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4210850 [patent_doc_number] => 06028243 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Mice and cells with a homozygous disruption in the RNase L gene and methods therefore' [patent_app_type] => 1 [patent_app_number] => 8/943956 [patent_app_country] => US [patent_app_date] => 1997-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 11 [patent_no_of_words] => 11298 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028243.pdf [firstpage_image] =>[orig_patent_app_number] => 943956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645595 [patent_doc_number] => 06472374 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Endometrial function' [patent_app_type] => B1 [patent_app_number] => 08/860047 [patent_app_country] => US [patent_app_date] => 1997-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 8766 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472374.pdf [firstpage_image] =>[orig_patent_app_number] => 08860047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 535325 [patent_doc_number] => 07176186 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-02-13 [patent_title] => 'Stimulation of cell-mediated immune responses by targeted particulate genetic immunization' [patent_app_type] => utility [patent_app_number] => 08/931219 [patent_app_country] => US [patent_app_date] => 1997-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10433 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/176/07176186.pdf [firstpage_image] =>[orig_patent_app_number] => 08931219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1409965 [patent_doc_number] => 06521225 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-18 [patent_title] => 'AAV vectors' [patent_app_type] => B1 [patent_app_number] => 08/921497 [patent_app_country] => US [patent_app_date] => 1997-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9809 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521225.pdf [firstpage_image] =>[orig_patent_app_number] => 08921497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 627224 [patent_doc_number] => 07135608 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-11-14 [patent_title] => 'Site-specific recombination in eukaryotes and constructs useful therefor' [patent_app_type] => utility [patent_app_number] => 08/919501 [patent_app_country] => US [patent_app_date] => 1997-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8327 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/135/07135608.pdf [firstpage_image] =>[orig_patent_app_number] => 08919501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4297604 [patent_doc_number] => 06187306 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same' [patent_app_type] => 1 [patent_app_number] => 8/906029 [patent_app_country] => US [patent_app_date] => 1997-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9480 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187306.pdf [firstpage_image] =>[orig_patent_app_number] => 906029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 774352 [patent_doc_number] => 07002027 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-21 [patent_title] => 'Compositions and methods for therapeutic use' [patent_app_type] => utility [patent_app_number] => 08/889355 [patent_app_country] => US [patent_app_date] => 1997-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10498 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/002/07002027.pdf [firstpage_image] =>[orig_patent_app_number] => 08889355 [rel_patent_id] =>[rel_patent_doc_number] =>)